Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy

Fig. 2

Immunohistochemistry for the autophagy-associated markers beclin 1 and LC3 and apoptosis-associated markers TUNEL and M30. The cytoplasmic staining of beclin 1, LC3, and M30 and nuclear staining of TUNEL were assessed (Scale bar = 100 μm). Weak and strong staining was regarded as positive. -: negative staining, +: weak staining, ++: strong staining

Back to article page